Clinical trial
Real-world Study on the Efficacy and Safety of Ticagrelor in the Treatment of Ischemic Cerebrovascular Disease
NCT05716646 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-world Study on the Efficacy and Safety of Ticagrelor in the Treatment of Ischemic Cerebrovascular Disease
- Lead sponsor
- Qianfoshan Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 30, 2023
- Completion date
- December 31, 2028
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cerebral infarction, ischemic cerebrovascular disease, nervous system diseases, stroke